Evidence map›Paper›PMID 32209467›Full record

ArticleCell reports2020

Acute Plasmodium Infection Promotes Interferon-Gamma-Dependent Resistance to Ebola Virus Infection.

Kai J Rogers, Olena Shtanko, Rahul Vijay, Laura N Mallinger, Chester J Joyner, Mary R Galinski, Noah S Butler, Wendy Maury

Open access · goldAbstract read
In one paragraph

Article in Cell reports, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed, 1 pooled it
0.3field-weighted citation impact, top 29% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 1 synthesis or guideline pooled it, 20 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Review
  15. Review
  16. Article
  17. Review
  18. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 1 country.

Kai J RogersDepartment of Microbiology and Immunology, University of Iowa, Iowa City, IA 52242, USA.
Olena ShtankoHost-Pathogen Interactions, Texas Biomedical Research Institute, San Antonio, TX 78227, USA.
Rahul VijayDepartment of Microbiology and Immunology, University of Iowa, Iowa City, IA 52242, USA.
Laura N MallingerDepartment of Microbiology and Immunology, University of Iowa, Iowa City, IA 52242, USA.
Chester J JoynerDivision of Pulmonary, Allergy, Critical Care & Sleep Medicine, Department of Medicine, Emory University, Atlanta, GA 30322, USA; Malaria Host-Pathogen Interaction Center, Emory Vaccine Center, Yerkes National Primate Center, Emory University, Atlanta, GA 30322, USA.
Mary R GalinskiMalaria Host-Pathogen Interaction Center, Emory Vaccine Center, Yerkes National Primate Center, Emory University, Atlanta, GA 30322, USA; Division of Infectious Diseases, Department of Medicine, Emory University School of Medicine, Atlanta, GA, USA.
Noah S ButlerDepartment of Microbiology and Immunology, University of Iowa, Iowa City, IA 52242, USA; Interdisciplinary Graduate Program in Immunology, University of Iowa, Iowa City, IA 52242, USA.
Wendy MauryDepartment of Microbiology and Immunology, University of Iowa, Iowa City, IA 52242, USA; Interdisciplinary Graduate Program in Immunology, University of Iowa, Iowa City, IA 52242, USA. Electronic address: wendy-maury@uiowa.edu.
University of Iowa · USEmory University · USTexas Biomedical Research Institute · US

Funding

Yerkes National Primate Research Center Role of type-I IFN in regulating COVID-19 induced inflammation and pathogenesisP51OD011132 · OD · EMORY UNIVERSITY · PI Joon Sup Lee · 2012 to 2026
$167.0M
The University of Iowa Clinical and Translational Science AwardUL1TR002537 · NCATS · UNIVERSITY OF IOWA · PI HANSEN, MARLAN R, WINOKUR, PATRICIA · 2018 to 2022
$20.0M
MEDICAL SCIENTIST TRAINING PROGRAMT32GM007337 · NIGMS · UNIVERSITY OF IOWA · PI GEYER, PAMELA K., LENTZ, STEVEN R · 1985 to 2020
$15.9M
Regulation of Plasmodium-specific CD4+ T CellsR01AI127481 · NIAID · UNIVERSITY OF OKLAHOMA HLTH SCIENCES CTR · PI Noah Sullivan Butler · 2016 to 2026
$3.8M
Development and function of CD4+ memory T cells during malariaR01AI125446 · NIAID · UNIVERSITY OF OKLAHOMA HLTH SCIENCES CTR · PI Noah Sullivan Butler · 2016 to 2026
$3.7M
Predoctoral Training in the Pharmacological SciencesT32GM067795 · NIGMS · UNIVERSITY OF IOWA · PI STRACK, STEFAN · 2004 to 2021
$3.4M
Modeling Filovirus Infection of and Trafficking through SkinR01AI134733 · NIAID · UNIVERSITY OF IOWA · PI MAURY, WENDY JEAN · 2018 to 2021
$3.1M
Filoviral glycoprotein/cellular protein interactionsR01AI077519 · NIAID · UNIVERSITY OF IOWA · PI MAURY, WENDY JEAN · 2010 to 2014
$1.7M
Mechanisms and consequences of Plasmodium/Ebola virus co-infectionsR21AI139902 · NIAID · UNIVERSITY OF IOWA · PI MAURY, WENDY JEAN · 2018 to 2019
$453k
NCATS NIH HHS UL1 TR002537NIAID NIH HHS HHSN272201200031CNIAID NIH HHS R01 AI077519NIAID NIH HHS R01 AI125446NIAID NIH HHS R01 AI127481NIAID NIH HHS R01 AI134733NIAID NIH HHS R21 AI139902NIGMS NIH HHS T32 GM007337NIGMS NIH HHS T32 GM067795NIH HHS P51 OD011132
6 · The paper itself

Abstract

During the 2013-2016 Ebola virus (EBOV) epidemic, a significant number of patients admitted to Ebola treatment units were co-infected with Plasmodium falciparum, a predominant agent of malaria. However, there is no consensus on how malaria impacts EBOV infection. The effect of acute Plasmodium infection on EBOV challenge was investigated using mouse-adapted EBOV and a biosafety level 2 (BSL-2) model virus. We demonstrate that acute Plasmodium infection protects from lethal viral challenge, dependent upon interferon gamma (IFN-γ) elicited as a result of parasite infection. Plasmodium-infected mice lacking the IFN-γ receptor are not protected. Ex vivo incubation of naive human or mouse macrophages with sera from acutely parasitemic rodents or macaques programs a proinflammatory phenotype dependent on IFN-γ and renders cells resistant to EBOV infection. We conclude that acute Plasmodium infection can safeguard against EBOV by the production of protective IFN-γ. These findings have implications for anti-malaria therapies administered during episodic EBOV outbreaks in Africa.

Indexed as

AnimalsDisease ResistanceEbolavirusFemaleGlycoproteinsHemorrhagic Fever, EbolaInterferon-gammaInterferon gamma ReceptorMacrophages, PeritonealMalariaMice, Inbred BALB CMice, Inbred C57BLPlasmodium falciparumReceptor, Interferon alpha-betaReceptors, InterferonVesiculovirusGlycoproteinsIfnar1 protein, mouseInterferon-gammaInterferon gamma ReceptorReceptor, Interferon alpha-betaReceptors, Interferonco-infectionEbola virusfilovirusinnate immunityinterferon gammamacrophagemacrophage polarizationmalariaPlasmodium

Identifiers

PMID32209467
PMCPMC7172281
OpenAlexW3014070490

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.